v2.4.0.8
Stockholders' Equity
12 Months Ended
Jun. 29, 2013
Equity [Abstract]  
Stockholders' Equity

9. Stockholders’ Equity

Preferred Stock

We are authorized, subject to limitations imposed by Delaware law, to issue up to a total of 10,000,000 shares of preferred stock in one or more series without stockholder approval. Our board of directors has the power to establish from time to time the number of shares to be included in each series and to fix the rights, preferences, and privileges of the shares of each wholly unissued series and any of its qualifications, limitations, or restrictions. Our board of directors can also increase or decrease the number of shares of a series, but not below the number of shares of that series then outstanding, without any further vote or action by the stockholders.

 

Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could harm the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring, or preventing a change in control of our company and might harm the market price of our common stock and the voting power and other rights of the holders of common stock. As of the end of fiscal 2013, there were no shares of preferred stock outstanding and we have no current plans to issue any shares of preferred stock.

Shares Reserved for Future Issuance

Shares of common stock reserved for future issuance as of the end of fiscal 2013 were as follows:

 

Stock options outstanding

     6,030,287   

Deferred stock units outstanding

     1,005,435   

Market stock units outstanding

     67,400   

Awards available for grant under all share-based compensation plans

     1,674,601   
  

 

 

 

Reserved for future issuance

     8,777,723   
  

 

 

 

Treasury Stock

In July 2013, our board of directors authorized an additional $100 million for our common stock purchase program bringing the cumulative authorization to $620.0 million, expiring in October 2015. The program authorizes us to repurchase our common stock in the open market or in privately negotiated transactions depending upon market conditions and other factors. The number of shares repurchased and the timing of repurchases is based on the level of our cash balances, general business and market conditions, and other factors, including alternative investment opportunities. Common stock repurchased under this program is held as treasury stock. As of the date of the additional authorization we had $159.8 million remaining under our common stock repurchase program.